TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34582171

Group type: EXPERIMENTAL
Intervention: Piecewise isothermal nucleic acid test (PINAT) for SARS-CoV-2
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Piecewise isothermal nucleic acid test (PINAT) for Influenza A
Number of subjects: 370
Study: 36197272

Group type: EXPERIMENTAL
Intervention: Long-term extended nursing services plus atezolizumab (LTENS-ATZ)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Long-term conventional nursing plus atezolizumab (LTCN-ATZ)
Number of subjects: 126
Study: 33746633

Group type: EXPERIMENTAL
Intervention: Dental trauma prevalence assessment
Number of subjects: 7902

Group type: EXPERIMENTAL
Intervention: Assessment of predisposing factors for dental trauma
Number of subjects: 7902
Study: 33125702

Group type: EXPERIMENTAL
Intervention: Oral tranexamic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35287501

Group type: EXPERIMENTAL
Intervention: Yi Jin Bang (YJB) exercise
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Usual exercise therapy (UET)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 54
Study: 33280529

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control
Number of subjects: 43
Study: 32660611

Group type: EXPERIMENTAL
Intervention: Ravulizumab plus Best Supportive Care (BSC)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Best Supportive Care (BSC) alone
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Ravulizumab plus BSC
Number of subjects: 270
Study: 35714477

Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Apalutamide
Number of subjects: 0
Study: 32554760

Group type: EXPERIMENTAL
Intervention: mycophenolate mofetil
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: rituximab
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: azathioprine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: IV immunoglobulin (IVIG)
Number of subjects: 70

Group type: COMPARATOR
Intervention: multiple sclerosis (MS) disease-modifying agents
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: overall treatments
Number of subjects: 70
Study: 35697792

Group type: EXPERIMENTAL
Intervention: SMS messages to parents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phone calls to parents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined treatment (SMS messages and phone calls)
Number of subjects: 0
Study: 34128044

Group type: EXPERIMENTAL
Intervention: Elevated estradiol to surge of ≤4 days
Number of subjects: 1891

Group type: COMPARATOR
Intervention: Elevated estradiol to surge of >4 days
Number of subjects: 1891

Group type: EXPERIMENTAL
Intervention: Follicular length ≤15 days
Number of subjects: 1891

Group type: COMPARATOR
Intervention: Follicular length >15 days
Number of subjects: 1891
Study: 32160158

Group type: EXPERIMENTAL
Intervention: Pediatricians' knowledge and practices regarding menstruation
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Pediatricians' practices regarding anticipatory guidance
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Pediatricians' practices regarding menstruation discussions
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Pediatricians' practices regarding menstrual cycle evaluation
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Male pediatricians' practices
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Knowledge gaps in menstruation-related topics
Number of subjects: 462
Study: 34057540

Group type: EXPERIMENTAL
Intervention: bicortical CBT screws
Number of subjects: 20

Group type: COMPARATOR
Intervention: pericortical CBT screws
Number of subjects: 20
Study: 34773384

Group type: EXPERIMENTAL
Intervention: Active Cycle of Breathing Technique (ACBT)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Conventional chest physiotherapy (control)
Number of subjects: 291
Study: 32520418

Group type: EXPERIMENTAL
Intervention: Active Beet+GFJ (250 mL grapefruit juice + 70 mL beetroot juice)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Active Beet+H2O (250 mL water + 70 mL beetroot juice)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo Beet+GFJ (placebo beetroot juice + 250 mL grapefruit juice)
Number of subjects: 11
Study: 32772246

Group type: EXPERIMENTAL
Intervention: Traditional (TRAD) training
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Accentuation eccentric loading (AEL) training
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (CON) training
Number of subjects: 28
Study: 36104706

Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training (RAGT) with 15 sessions
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional rehabilitation alone
Number of subjects: 40
Study: 33617341

Group type: EXPERIMENTAL
Intervention: Endovascular therapy (EVT)
Number of subjects: 9
Study: 35044886

Group type: EXPERIMENTAL
Intervention: Cognitive Enhancement Therapy (CET)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Enriched Supportive Therapy (EST)
Number of subjects: 88
Study: 35197335

Group type: EXPERIMENTAL
Intervention: Physician-optimised self-management of postpartum blood pressure via a smartphone app with algorithm-driven medication titration
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care by the healthcare team
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Physician-optimised self-management
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study: 32353162

Group type: EXPERIMENTAL
Intervention: MGS0274 besylate (TS-134) at doses of 5–80 mg (single and multiple doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34788830

Group type: EXPERIMENTAL
Intervention: Highest hydrocortisone dose in the evening
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Highest hydrocortisone dose in the morning
Number of subjects: 39

Group type: COMPARATOR
Intervention: Both treatment strategies
Number of subjects: 39
Study: 34593015

Group type: EXPERIMENTAL
Intervention: Therapist-supported internet-delivered behaviour therapy (BIP TIC) for 10-12 weeks
Number of subjects: 220

Group type: COMPARATOR
Intervention: Therapist-supported internet-delivered education (active control) for 10-12 weeks
Number of subjects: 220
Study: 32195768

Group type: EXPERIMENTAL
Intervention: 30 g intrinsically L‐[1‐C]‐phenylalanine‐labeled casein protein before sleep (PRO)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (EX)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 30 g intrinsically L‐[1‐C]‐phenylalanine‐labeled casein protein before sleep (EX + PRO)
Number of subjects: 36
Study: 33476707

Group type: EXPERIMENTAL
Intervention: BIOSYNEX COVID‐19 BSS (IgG/IgM)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Humasis COVID‐19 IgG/IgM Test
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: LYHER COVID‐19 IgM/IgG Rapid Test
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SIENNA™ COVID‐19 (IgG/IgM) Rapid Test Cassette
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: NG‐BIOTECH COVID‐19 (IgG/IgM)
Number of subjects: 100
Study: 33176462

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 13885

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 13885
Study: 35774045

Group type: EXPERIMENTAL
Intervention: CLS02021 cream
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 50
Study: 33711654

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (40 μg d3‐vitamin)
Number of subjects: 0
Study: 33002541

Group type: EXPERIMENTAL
Intervention: Stereotactic Ablative Radiation Therapy (SABR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 0
Study: 32940131

Group type: EXPERIMENTAL
Intervention: Split-Belt Treadmill (SBT) with changing ratios
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Split-Belt Treadmill (SBT)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Tied-Belt Treadmill (TBT)
Number of subjects: 81
Study: 35579642

Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone (initially 0.6-0.8 mg/kg/d, maximum 48 mg/d, weaning by 8 mg/d/mo)
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone (reduced dose 0.4 mg/kg/d, maximum 32 mg/d, weaning by 4 mg/d/mo)
Number of subjects: 503

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone
Number of subjects: 503
Study: 34158518

Group type: EXPERIMENTAL
Intervention: ID‐JPL934
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 36098968

Group type: EXPERIMENTAL
Intervention: Vitamin D3, 2000 IU/d
Number of subjects: 25057

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids, 1 g/d
Number of subjects: 25057

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 25057
Study: 33630408

Group type: EXPERIMENTAL
Intervention: Nitrate supplementation (300 mg potassium nitrate/day)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Placebo (300 mg potassium chloride/day)
Number of subjects: 231
Study: 33129278

Group type: EXPERIMENTAL
Intervention: Direct patient recruitment materials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of community pharmacists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Free medications
Number of subjects: 0
Study: 33688084

Group type: EXPERIMENTAL
Intervention: MRCs with explanation about 'switching completely'
Number of subjects: 2914

Group type: COMPARATOR
Intervention: MRCs with explanation absent
Number of subjects: 2914

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2914

Group type: EXPERIMENTAL
Intervention: MRCs with certain language
Number of subjects: 2914

Group type: EXPERIMENTAL
Intervention: MRCs with hypothetical language
Number of subjects: 2914

Group type: EXPERIMENTAL
Intervention: MRCs highlighting reduced risk for a single disease
Number of subjects: 2914

Group type: EXPERIMENTAL
Intervention: MRCs highlighting reduced risk for multiple diseases
Number of subjects: 2914

Group type: EXPERIMENTAL
Intervention: MRCs
Number of subjects: 2914
Study: 33515740

Group type: EXPERIMENTAL
Intervention: Prebiotic inulin (16 g/d)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Prebiotic inulin
Number of subjects: 106
Study: 35924292

Group type: EXPERIMENTAL
Intervention: Early sheath removal (n = 171)
Number of subjects: 349

Group type: COMPARATOR
Intervention: Late sheath removal (n = 178)
Number of subjects: 349
Study: 33909725

Group type: EXPERIMENTAL
Intervention: Human chorionic amniotic membrane
Number of subjects: 8

Group type: COMPARATOR
Intervention: Platelet-rich fibrin
Number of subjects: 8
Study: 34479461

Group type: EXPERIMENTAL
Intervention: Minimal invasive extracorporeal circulation (MiECC)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Conventional extracorporeal circulation (CECC)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 240
Study: 32912659

Group type: EXPERIMENTAL
Intervention: Virtual grand rounds (VGR)
Number of subjects: 18
Study: 32078409

Group type: EXPERIMENTAL
Intervention: In-person social communication skills training (n = 17)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Telehealth social communication skills training (n = 19)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Communication partners trained (in-person or telehealth)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Historical control group (n = 15)
Number of subjects: 51
Study: 35385798

Group type: EXPERIMENTAL
Intervention: Alert intervention
Number of subjects: 1310

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1310
Study: 33945526

Group type: EXPERIMENTAL
Intervention: Cash incentives (US$7) for retesting at 3 and 6 months (total US$14)
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: Deposit contracts (voluntary deposit of US$6 at baseline and at 3 months)
Number of subjects: 524

Group type: COMPARATOR
Intervention: No incentive (control)
Number of subjects: 524
Study: 33237182

Group type: EXPERIMENTAL
Intervention: Plastibell® (PB group)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Conventional technique (CV group)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Conventional with subcuticular stitches (SC group)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 149
Study: 35344750

Group type: EXPERIMENTAL
Intervention: Surufatinib
Number of subjects: 242

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 242
Study: 35786512

Group type: EXPERIMENTAL
Intervention: 5,000 IU of vitamin D
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 33515938

Group type: COMPARATOR
Intervention: Alectinib 600 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alectinib 300 mg twice daily
Number of subjects: 0
Study: 32702299

Group type: EXPERIMENTAL
Intervention: 1 × 10^11 viral particles
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: 5 × 10^10 viral particles
Number of subjects: 508

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 508
Study: 36293616

Group type: EXPERIMENTAL
Intervention: Very Low-Calorie Ketogenic Diet (VLCKD)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Mediterranean Diet (MD)
Number of subjects: 268
Study: 32627352

Group type: EXPERIMENTAL
Intervention: Purified human pancreatic islets (PHPI) transplantation
Number of subjects: 24
Study: 33360163

Group type: EXPERIMENTAL
Intervention: MS-222 at 300 mg/L
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: MS-222 at 100 mg/L
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: MS-222 at 200 mg/L
Number of subjects: 28

Group type: COMPARATOR
Intervention: Non-anesthetized
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: MS-222 (all concentrations)
Number of subjects: 28
Study: 32500393

Group type: EXPERIMENTAL
Intervention: Water
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Diet drink
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control (SSB consumption)
Number of subjects: 158
Study: 33210975

Group type: EXPERIMENTAL
Intervention: Corneal collagen cross-linking (CXL, Photrexa + KXL combination product)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No corneal collagen cross-linking (no CXL)
Number of subjects: 100
Study: 36459731

Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: F/V diet
Number of subjects: 459

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 459
Study: 33111977

Group type: EXPERIMENTAL
Intervention: Complex decongestive physiotherapy (CDP)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Home program
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control
Number of subjects: 21
Study: 32649494

Group type: EXPERIMENTAL
Intervention: Permanent suture
Number of subjects: 204

Group type: COMPARATOR
Intervention: Delayed absorbable suture
Number of subjects: 204
Study: 35189818

Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine (AS-AQ)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 242
Study: 33989351

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided DNTP technique
Number of subjects: 256

Group type: COMPARATOR
Intervention: Palpation method
Number of subjects: 256
Study: 35946062

Group type: EXPERIMENTAL
Intervention: Acupuncture (High Expectancy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupuncture (Low Expectancy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sham Acupuncture (High Expectancy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sham Acupuncture (Low Expectancy)
Number of subjects: 0
Study: 33237254

Group type: EXPERIMENTAL
Intervention: #Tamojunto school‐based drug prevention program
Number of subjects: 6391

Group type: EXPERIMENTAL
Intervention: Baseline behavior problems
Number of subjects: 6391

Group type: EXPERIMENTAL
Intervention: Baseline alcohol use
Number of subjects: 6391

Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 6391
Study: 33107226

Group type: EXPERIMENTAL
Intervention: Novel endoscopic criteria for predicting tumor invasion depth in SESC
Number of subjects: 352

Group type: COMPARATOR
Intervention: Endoscopically mucosal vs submucosal cancers
Number of subjects: 352
Study: 33930187

Group type: EXPERIMENTAL
Intervention: Foley catheter with 500 ml weight attached
Number of subjects: 399

Group type: COMPARATOR
Intervention: Foley catheter without weight attached
Number of subjects: 399
Study: 33675423

Group type: EXPERIMENTAL
Intervention: Concentric cycling (CONC-M: 50% maximum concentric cycling power output)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Eccentric cycling (ECC-M: 50% POmax)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-intensity eccentric cycling (ECC-H: 100% POmax)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 10
Study: 32672798

Group type: EXPERIMENTAL
Intervention: Adjuvant systemic chemotherapy
Number of subjects: 393

Group type: COMPARATOR
Intervention: Active surveillance
Number of subjects: 393
Study: 34709347

Group type: EXPERIMENTAL
Intervention: Geographic atrophy (GA)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Baseline GA area
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Baseline GA perimeter
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Lesion number
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Circularity index
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Retinal eccentricity
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Percentage area affected by GA
Number of subjects: 237
Study: 32305259

Group type: EXPERIMENTAL
Intervention: Mifepristone-misoprostol
Number of subjects: 297

Group type: COMPARATOR
Intervention: Misoprostol alone
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Mifepristone treatment
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 297
Study: 35442432

Group type: EXPERIMENTAL
Intervention: SHUTi (standard internet-delivered CBT-I)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: SHUTi-BWHS (culturally tailored internet-delivered CBT-I)
Number of subjects: 333

Group type: COMPARATOR
Intervention: PE (patient education about sleep)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: SHUTi-BWHS
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: SHUTi and SHUTi-BWHS (combined)
Number of subjects: 333
Study: 32048365

Group type: EXPERIMENTAL
Intervention: Saffron supplement (100 mg/day)
Number of subjects: 66
Study: 35238652

Group type: EXPERIMENTAL
Intervention: MuIS+ (n=24)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Surgical limb (SX)
Number of subjects: 70
Study: 34059274

Group type: EXPERIMENTAL
Intervention: 1.5% dipotassium oxalate monohydrate (KOX) oral rinse
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo oral rinse
Number of subjects: 89

Group type: COMPARATOR
Intervention: Negative Control oral rinse
Number of subjects: 89
Study: 33878350

Group type: EXPERIMENTAL
Intervention: Warning topics (text‐only, icon, graphic)
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Icon warnings
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Graphic warnings
Number of subjects: 1078
Study: 32087011

Group type: EXPERIMENTAL
Intervention: Shiny CRT Calculator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cluster randomized designs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cross-sectional and cohort designs
Number of subjects: 0
Study: 36140138

Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) based AD diagnosis using surface-enhanced Raman spectroscopy (SERS) fingerprints of human cerebrospinal fluid (CSF)
Number of subjects: 0
Study: 33559538

Group type: EXPERIMENTAL
Intervention: Secure prime condition
Number of subjects: 154

Group type: COMPARATOR
Intervention: Neutral prime condition
Number of subjects: 154
Study: 33027722

Group type: EXPERIMENTAL
Intervention: Hysteroscopic injection (HI)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Cervical injection (CI)
Number of subjects: 151
Study: 35064823

Group type: EXPERIMENTAL
Intervention: Prophylactic long-acting G-CSF
Number of subjects: 68

Group type: COMPARATOR
Intervention: Prophylactic standard G-CSF
Number of subjects: 68
Study: 32135042

Group type: EXPERIMENTAL
Intervention: Antistigma intervention curriculum (ASIC)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 220
Study: 35139070

Group type: EXPERIMENTAL
Intervention: IDA (ivermectin, diethylcarbamazine, and albendazole)
Number of subjects: 4563

Group type: COMPARATOR
Intervention: DA (diethylcarbamazine and albendazole)
Number of subjects: 4563

Group type: EXPERIMENTAL
Intervention: IDA
Number of subjects: 4563

Group type: COMPARATOR
Intervention: DA
Number of subjects: 4563
Study: 33672908

Group type: EXPERIMENTAL
Intervention: Crossover turn
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Somersault turn
Number of subjects: 18

Group type: COMPARATOR
Intervention: All turning techniques
Number of subjects: 18
Study: 35732385

Group type: EXPERIMENTAL
Intervention: Intramuscular midazolam (0.05 mg/kg)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo (normal saline 0.01 mL/kg)
Number of subjects: 134
Study: 33121474

Group type: EXPERIMENTAL
Intervention: Intravenous propofol (10 ml propofol with 1 ml 2% lidocaine), 0.5‐1 mg/kg before endotracheal suctioning
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control group (endotracheal suctioning only)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Intravenous propofol
Number of subjects: 208
Study: 32627619

Group type: EXPERIMENTAL
Intervention: Transoral CO2 laser therapy
Number of subjects: 40
Study: 33218508

Group type: EXPERIMENTAL
Intervention: Pilates Matwork exercises (50 min, twice a week for 4 months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control Group (no intervention)
Number of subjects: 40
Study: 34170371

Group type: EXPERIMENTAL
Intervention: Procollagen type I C‐terminal pro‐peptide (PICP)
Number of subjects: 2773

Group type: EXPERIMENTAL
Intervention: Galectin‐3 (Gal‐3)
Number of subjects: 2773

Group type: EXPERIMENTAL
Intervention: PICP and Gal‐3 interaction
Number of subjects: 2773

Group type: EXPERIMENTAL
Intervention: PICP, Gal‐3 and their interaction
Number of subjects: 2773